MergerLinks Header Logo

Announced

Completed

Alliance Pharma completed the acquisition of ScarAway from Perrigo for £14.8m.

Synopsis

Alliance Pharma, a distributor of consumer healthcare brands and prescription medicines, completed the acquisition of ScarAway, a silicone-based scar treatment brand, from Perrigo, a manufacturer of over-the-counter self-care products and supplier of infant formulas for the store brand market, for £14.8m. "I'm delighted to have completed such a strategically important and earnings enhancing acquisition for Alliance which creates our first fully global brand in Kelo-cote and significantly enhances our presence in the largest consumer healthcare market in the world," Peter Butterfield, Alliance Chief Executive Officer.

Show Details & Financials

Market Context

Sort

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US